$363 Million is the total value of Integral Health Asset Management, LLC's 71 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -20,000 | -100.0% | -0.03% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -15,000 | -100.0% | -0.11% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -10,000 | -100.0% | -0.32% | – |
| SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -10,000 | -100.0% | -0.37% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -20,000 | -100.0% | -0.43% | – |
| ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.60% | – |
| INSM | Exit | INSMED INC | $0 | – | -70,000 | -100.0% | -0.68% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -50,000 | -100.0% | -0.74% | – |
| PODD | Exit | INSULET CORP | $0 | – | -10,000 | -100.0% | -0.74% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -14,000 | -100.0% | -0.86% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -500,000 | -100.0% | -0.89% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -50,000 | -100.0% | -0.90% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -40,000 | -100.0% | -1.05% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -65,000 | -100.0% | -1.22% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -200,000 | -100.0% | -1.29% | – |
| SGFY | Exit | SIGNIFY HEALTH INC | $0 | – | -160,000 | -100.0% | -1.34% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -20,000 | -100.0% | -1.39% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -175,000 | -100.0% | -1.59% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -25,000 | -100.0% | -1.82% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -90,000 | -100.0% | -1.98% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -150,000 | -100.0% | -2.74% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -50,000 | -100.0% | -2.79% | – |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -35,000 | -100.0% | -2.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-08-30
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.